I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Preclinical development of ACT-1004-1239, a potent and sele..:
Pouzol, Laetitia
NNT: 2022UPASQ021. , 2022
Link:
https://theses.hal.science/tel-03736371
RT Journal T1
Preclinical development of ACT-1004-1239, a potent and selective CXCR7/ACKR3 antagonist in multiple sclerosis treatment ; Développement préclinique d'ACT-1004-1239, un antagoniste puissant et sélectif du récepteur CXCR7/ACKR3 pour le traitement de la sclérose en plaques
UL https://suche.suub.uni-bremen.de/peid=base-ftuniparissaclay:oai:HAL:tel-03736371v1&Exemplar=1&LAN=DE A1 Pouzol, Laetitia PB HAL CCSD YR 2022 K1 Remyelination K1 Multiple sclerosis K1 CXCL12 and CXCL11 chemokine ligands K1 CXCR3 and CXCR4 chemokine receptors K1 ACKR3/CXCR7 K1 Immunomodulation K1 CXCR3 et CXCR4 K1 CXCL12 et CXCL11 K1 Remyélinisation K1 Sclérose en plaques K1 [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology K1 [SDV.SP.MED]Life Sciences [q-bio]/Pharmaceutical sciences/Medication JF NNT: 2022UPASQ021 LK http://dx.doi.org/https://theses.hal.science/tel-03736371 DO https://theses.hal.science/tel-03736371 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)